U.S. clinical labs face mounting regulatory challenges and shifting payer dynamics that are fundamentally changing how laboratory revenue cycle management (RCM) must be handled. Staying ahead means mastering compliance, optimizing payor contracting, and modernizing medical billing for laboratories to protect revenue and reduce expensive denials. If you manage a clinical lab, you’ve likely experienced how yesterday’s billing strategies no longer deliver. To survive – and thrive – you need to rethink your approach.
Regulatory Trends Shaping Laboratory Revenue Cycle Management
The regulatory spotlight on clinical laboratories in the U.S. is intensifying. The Centers for Medicare & Medicaid Services (CMS), the Food and Drug Administration (FDA), and new federal mandates have made lab RCM
